PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Genfit and Ipsen announce elafibranor results

ELATIVE, a randomised PBC trial involving 161 patients, has successfully met its primary endpoint. Ipsen and Genfit have announced positive data from the pivotal ...
Continue Reading →
News

University of Oxford and PrecisionLife reach data agreement

PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis. PrecisionLife – a company focusing on precision medicine in chronic d...
Continue Reading →
News

Connect in Pharma 2023 Revealed Latest Trends in Pharmaceutical Manufacturing and Drug Delivery

Hosting leading industry experts from across Europe, Connect in Pharma 2023 revealed future trends in pharma and AI, sustainability, and preventative medicine during...
Continue Reading →
News

Tower Cold Chain Expands Presence with Opening of American Centre of Excellence

Pharmaceutical thermal protection specialist Tower Cold Chain has opened its new headquarters in the Americas region. Located in Philadelphia, just 1.6 miles ...
Continue Reading →
News

Positive results for Evgen’s rhabdomyosarcoma therapy

Update on radio sensitising impact of SFX-01 when treating common soft tissue sarcoma condition. Evgen Pharma – a company focusing on sulforaphane-based therapies...
Continue Reading →
News

MinervaX reveals completion of vaccine trial enrolment

The company is seeking to address the worldwide impact of group B streptococcus in older adults. MinervaX – a company developing a prophylactic vaccine against gr...
Continue Reading →
News

CHMP gives positive opinion recommending authorisation to GSK’s CKD drug

Chronic kidney disease affects roughly 700 million patients worldwide. Global biopharmaceutical company GSK has announced that the European Medicines Agency’s (EM...
Continue Reading →
News

AstraZeneca’s Soliris given EU CHMP recommendation for marketing authorisation

The authorisation would include certain patients with refractory generalised myasthenia gravis. UK-based biopharmaceutical company AstraZeneca has announced that ...
Continue Reading →
News

Blood Cancer UK extends collaboration with RareCan

The organisations will focus on the delivery of clinical trials which concentrate on rare cancers. Blood Cancer UK has renewed its partnership with RareCan with a...
Continue Reading →
News

Nanopharmaceutics and PrecisionLife in research collaboration

Companies’ precision medicine approach has the potential to increase clinical trial success rates. PrecisionLife – a company focusing on precision medicine – and ...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026